The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy
Open Access
- 4 November 2024
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 65 (13) , 43
Abstract
Purpose: The purpose of this study was to delineate the neuroprotective mechanisms of topical 2% ripasudil (Rip), a Rho kinase (ROCK) inhibitor. Methods: In 340 mice, scheduled 2% Rip or balanced salt solution (BSS) saline drops were intermittently, unilaterally delivered. Intracameral microbead glaucoma (GL) injection increased intraocular pressure (IOP) from 1 day to 6 weeks (6W), whereas other mice underwent optic nerve (ON) crush. Retinal ganglion cell (RGC) loss was assessed using retinal wholemount anti-RNA Binding Protein with Multiple Splicing (RBPMS) labeling and ON axon counts. Axonal transport was quantified with β-amyloid precursor protein (APP) immunolocalization. Micro-Western (Wes) analysis quantified protein expression. Immunofluorescent expression of ROCK pathway molecules, quantitative astrocyte structural changes, and ON biomechanical strains (explanted eyes) were evaluated. ROCK activity assays were conducted in separate ON regions. Results: At 6W GL, mean RGC axon loss was 6.6 ± 13.3% in Rip and 36.3 ± 30.9% in BSS (P = 0.04, n = 10/group). RGC soma loss after crush was lower with Rip (68.6 ± 8.2%) than BSS (80.5 ± 5.7%, P = 0.006, n = 10/group). After 6W GL, RGC soma loss was lower with Rip (34 ± 5.0%) than BSS (51 ± 8.1%, P = 0.03, n = 10/group). Axonal transport of APP within the unmyelinated ON (UON) was unaffected by Rip. Maximum principal mechanical strains increased similarly in Rip and BSS-treated mice. Retinal ROCK 1 and 2 activity was reduced by Rip in GL eyes. The pROCK2/ROCK2 protein ratio rose in the retina of BSS GL eyes, but not in Rip GL eyes. Conclusions: Topical Rip reduced RGC loss in GL and ON crush, with suppression of ROCK signaling in the retina and ON. The neuroprotection mechanisms appear to involve effects on both RGC and astrocyte responses to IOP elevation.Keywords
This publication has 55 references indexed in Scilit:
- The Effect of TGF-β2 on Elastin, Type VI Collagen, and Components of the Proteolytic Degradation System in Human Optic Nerve AstrocytesInvestigative Ophthalmology & Visual Science, 2008
- ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cellsBrain, 2007
- Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of GlaucomaBioDrugs, 2007
- Enhanced survival and regeneration of axotomized retinal neurons by repeated delivery of cell-permeable C3-like Rho antagonistsNeurobiology of Disease, 2007
- Neurobiology of Glaucomatous Optic Neuropathy: Diverse Cellular Events in Neurodegeneration and NeuroprotectionMolecular Neurobiology, 2002
- Distribution and Expression of Transforming Growth Factor-β and Platelet-derived Growth Factor in the Normal and Glaucomatous Monkey Optic Nerve HeadsJapanese Journal of Ophthalmology, 2001
- Cofilin Phosphorylation and Actin Cytoskeletal Dynamics Regulated by Rho- and Cdc42-Activated Lim-Kinase 2Journal of Cell Biology, 1999
- Transforming growth factor beta isoforms in human optic nerve headsBritish Journal of Ophthalmology, 1999
- Rho-stimulated contractility drives the formation of stress fibers and focal adhesions.Journal of Cell Biology, 1996
- CHRONIC EXPERIMENTAL GLAUCOMA IN PRIMATES .2. EFFECT OF EXTENDED INTRAOCULAR-PRESSURE ELEVATION ON OPTIC-NERVE HEAD AND AXONAL-TRANSPORT1980